STAAR Surgical Company failed to receive the necessary stockholder votes to approve the merger agreement with Alcon.
As a result, STAAR intends to terminate the merger agreement.
No termination fee will be payable by either party, and STAAR will remain a standalone company trading on Nasdaq under the ticker symbol "STAA."
Failed Merger Approval
STAAR did not receive required stockholder votes to approve the Alcon merger.
Termination without Fees
No termination fee will be paid as STAAR terminates the agreement with Alcon.
Standalone Company
STAAR will remain publicly traded on Nasdaq under the symbol "STAA."
- STAAR acknowledges the vote outcome and expresses commitment to maximizing stockholder value as a standalone entity.
- The company emphasizes the innovative EVO ICL technology and its potential for global growth and adoption.
Despite the failed merger, STAAR Surgical remains focused on profitability and growth through its innovative technology and dedicated team.